- Research works
- 34 ▼ 91% vs 2013–17
- Citations
- 1.8k 51.7 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 56% world 28%
Not ranked overall: Sequella (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Sequella (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Immune Response, Vaccine, Mycobacterium tuberculosis, Tuberculosis and Antibiotic Resistance.
- Secondary Metabolites
- Human Health
- Global Collaboration
- Public Health
- Biological Evaluation
- Anticancer Agents
- Anticancer
- Synthesis
- Licorice
- Drug Discovery
- Inflammation
- Topoisomerases
- Nontuberculous Mycobacteria
- Antibiotic Resistance
- Mycobacterium tuberculosis
- Immune Response
- Diagnosis
- Epidemiology
- Treatment
- Vaccine
- Tuberculosis
- Mycobacterium avium
- DNA
- Cancer
- Pharmacology
- Glycyrrhizin
- Innovation
- Medicinal Chemistry
- Molecular Docking
- Antimicrobial
- Heterocyclic Compounds
- Climate Change
- Health Biotechnology
- Natural Products
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 34 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 34 words, with their numbers
- Epidemiology11▲ 8.3×8 topics
- Diagnosis11▲ 31×3 topics
- Treatment11▲ 24×3 topics
- Immune Response6▲ 31×3 topics
- Vaccine6▲ 47×3 topics
- Mycobacterium tuberculosis6▲ 280×1 topic
- Tuberculosis6▲ 337×1 topic
- Antibiotic Resistance4▲ 33×4 topics
- Mycobacterium avium4▲ 259×1 topic
- Nontuberculous Mycobacteria4▲ 259×1 topic
- DNA2▲ 229×1 topic
- Topoisomerases2▲ 229×1 topic
- Cancer2▲ 4.3×5 topics
- Inflammation2▲ 2.6×3 topics
- Pharmacology2▲ 18×2 topics
- Drug Discovery2▲ 13×3 topics
- Glycyrrhizin2▲ 123×1 topic
- Licorice2▲ 123×1 topic
- Innovation2▲ 4.8×2 topics
- Synthesis1▲ 7.2×4 topics
- Medicinal Chemistry1▲ 10×2 topics
- Anticancer1▲ 18×4 topics
- Molecular Docking1▲ 24×3 topics
- Anticancer Agents1▲ 13×2 topics
- Antimicrobial1▲ 13×3 topics
- Biological Evaluation1▲ 26×3 topics
- Heterocyclic Compounds1▲ 21×2 topics
- Public Health1▲ 2.3×2 topics
- Climate Change1◆ 1.10×1 topic
- Global Collaboration1▲ 72×1 topic
- Health Biotechnology1▲ 154×1 topic
- Human Health1▲ 36×1 topic
- Natural Products1▲ 17×1 topic
- Secondary Metabolites1▲ 30×1 topic
Which research topics does Sequella (United States) publish most on?
By volume in 2022–2025: Fungal Biology and Applications, Phytochemicals and Antioxidant Activities and Fungal and yeast genetics research.
- 1 Fungal Biology and Applications Pharmacology 0 works
- 2 Phytochemicals and Antioxidant Activities Biochemistry 0 works
- 3 Fungal and yeast genetics research Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sequella (United States)'s research output changed?
Output in 2018–2022 was 91% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Rockville
- United States Nuclear Regulatory Commission
- Signal Processing (United States)
- Center for Devices and Radiological Health
- Agency for Healthcare Research and Quality
- Orthopaedic Center
- Biomedical Research Institute
- Westat (United States)
- Research Applications (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.